E.coli-derived human RIMKLA recombinant protein (Position: Q19-K391).
Alternative Synonym:
RIMKLA, FAM80A, N-acetylaspartylglutamate synthase A, NAAG synthetase A, NAAGS, N-acetylaspartylglutamylglutamate synthase A, Ribosomal protein S6 modification-like protein A
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Reinheit:
Immunogen affinity purified.
Formulierung:
Liquid
Target-Kategorie:
N-acetylaspartylglutamate synthase A
Application Verdünnung:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten